Prime Medicine Inc (PRME) Wheel Strategy

Running a PRME wheel strategy lets you generate consistent premium income on Prime Medicine Inc while setting your own entry and exit prices on the underlying. Prime Medicine Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own PRME, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best PRME wheel strategy setups in real time.

The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on PRME, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable PRME wheel from a losing one.

Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. The company was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.

The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the PRME wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your PRME wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.